Julie Appleby reports on the implementation of the health care overhaul law, the interplay of health care treatments and costs, trends in health insurance, and policy issues affecting hospitals and other medical providers. Her KHN stories have appeared in USA Today, the Washington Post, the Philadelphia Inquirer and MSNBC, among others. Before joining KHN in March 2009, Appleby spent 10 years on the health care industry and policy beat for USA Today. She also worked at the San Francisco Chronicle
, the Financial Times
in London and the Contra Costa Times
in Walnut Creek, Calif. She serves on the board of the Association of Health Care Journalists and her education includes a Master of Public Health degree. | Contact: JulieA@kff.org
In their push to pass a sweeping health care overhaul this weekend, House Democrats unveiled a package of legislative fixes to lure undecided or opposed members of their party to the “yes” category.
A spike in prices charged by the largest Medicare drug plans raises a question about the impact regulated health insurance marketplaces would have on prices.
Workers at a Portland, Ore., steel mill soon will be able to pick a new type of health insurance: one with financial rewards to use proven treatments and disincentives to use less-effective surgeries and diagnostic tests.
Three veteran state insurance commissioners said they'd welcome federal advisory help, but draw the line at giving the government authority over rates, a power they say states should retain exclusively.
Struggling to close budget gaps brought on by the recession, some states are paring back health insurance programs for low-income people, even as growing joblessness boosts demand for help.
The president has long championed comparative effectiveness research, saying it would provide crucial information to determine which regimen or drug should be used. But critics fear that could lead to an effort to cut costs and restrict patients' choices.
Some lawmakers are considering a scaled-back health bill in place of the comprehensive legislation now stalled in Congress. But there's debate about whether popular insurance reforms, such as requiring insurers to accept applicants with health problems, can be successful without an unpopular individual insurance mandate.
The Democrats' health overhaul legislation is in trouble for many reasons, including key policy decisions that led many Americans to wonder whether they would wind up worse off.
Now that the Senate has passed a hotly debated health care bill, Congress is headed to the next step: House-Senate negotiations in January to try to hammer out a final version. Here's where things stand and how you might be affected.
Both the House and Senate health overhaul bills would force insurers to spend the vast majority of premium revenue on medical care for their customers, reducing the amount available for profits, executive salaries, sales and administration.